Medicare Enrolled
Dr. Scott Beach, M.D.
Interventional Cardiology · Cumming, GA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Beach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beach?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Beach
Dr. Scott Beach is an interventional cardiology specialist in Cumming, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Beach performed 7,741 Medicare services across 5,194 unique beneficiaries.
Between the years covered by Open Payments, Dr. Beach received a total of $13,302 from 52 pharmaceutical and/or device companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Beach is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 6% volume in GA
$13,302 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,741
Medicare services
Top 6% in GA for interventional cardiology
5,194
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~455 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,576 | $83 | $552 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,251 | $10 | $86 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,084 | $41 | $132 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 480 | $220 | $1,459 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
398 | $140 | $1,056 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
322 | $49 | $360 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
300 | $37 | $250 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
240 | $22 | $600 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
240 | $1,172 | $7,552 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
209 | $38 | $278 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
186 | $8 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $107 | $835 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $55 | $380 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
110 | $83 | $405 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
97 | $4 | $15 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
84 | $8 | $55 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
75 | $141 | $1,016 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $59 | $368 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
68 | $193 | $1,200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
67 | $15 | $95 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
66 | $136 | $992 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
58 | $91 | $620 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
55 | $313 | $2,419 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
45 | $30 | $203 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
44 | $18 | $160 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
43 | $6 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $123 | $741 |
| Cardiac catheterization | 42 | $190 | $1,543 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
34 | $174 | $1,292 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $126 | $1,030 |
| Chemical injection for multiple incompetent leg veins A procedure involving the injection of a chemical agent into several non-functioning veins in the leg. |
26 | $213 | $1,007 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
22 | $25 | $197 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
20 | $38 | $258 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
19 | $55 | $366 |
| Ultrasound of blood vessel, initial vessel An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel. |
17 | $733 | $5,996 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
15 | $1,023 | $7,735 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
15 | $830 | $7,012 |
| Additional blood vessel ultrasound evaluation An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one. |
13 | $131 | $969 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
11 | $71 | $494 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
27.5% medium
65.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,302
Total received (2018-2024)
Avg $1,900/year across 7 years
Top 32% in GA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
598
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,286 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,240
2023
$1,142
2022
$1,656
2021
$2,618
2020
$1,079
2019
$1,784
2018
$3,784
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$215
Amgen Inc.
$146
Novartis Pharmaceuticals Corporation
$108
PFIZER INC.
$93
Merck Sharp & Dohme LLC
$93
Edwards Lifesciences Corporation
$81
Novo Nordisk Inc
$80
ABIOMED
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Janssen Pharmaceuticals, Inc
$42
E.R. Squibb & Sons, L.L.C.
$25
Chiesi USA, Inc.
$24
Kestra Medical Technology Services, Inc.
$23
CVRx, Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
BIOTRONIK INC.
$21
SANOFI-AVENTIS U.S. LLC
$21
Esperion Therapeutics, Inc.
$21
Medtronic, Inc.
$20
Acarix USA Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
VivaQuant Inc, dba Rhythm Express
$16
Abbott Laboratories
$16
Top 3 companies account for 37.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,606
Janssen Pharmaceuticals, Inc
$1,490
Philips Electronics North America Corporation
$1,415
Amgen Inc.
$1,161
Novartis Pharmaceuticals Corporation
$956
Abbott Laboratories
$869
PFIZER INC.
$679
AstraZeneca Pharmaceuticals LP
$646
Boehringer Ingelheim Pharmaceuticals, Inc.
$487
Merck Sharp & Dohme LLC
$408
Amarin Pharma Inc.
$365
Regeneron Healthcare Solutions, Inc.
$220
Edwards Lifesciences Corporation
$218
SANOFI-AVENTIS U.S. LLC
$194
Gilead Sciences, Inc.
$190
ABIOMED
$159
BOSTON SCIENTIFIC CORPORATION
$157
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$155
Esperion Therapeutics, Inc.
$150
Merck Sharp & Dohme Corporation
$135
Avinger Inc.
$119
Medtronic Vascular, Inc.
$103
Allergan Inc.
$98
Chiesi USA, Inc.
$96
AngioDynamics, Inc.
$96
Medtronic, Inc.
$91
Kestra Medical Technology Services, Inc.
$88
Novo Nordisk Inc
$80
ATRICURE, INC.
$80
BIOTRONIK INC.
$61
ARALEZ PHARMACEUTICALS US INC.
$59
Tactile Systems Technology Inc
$56
Shockwave Medical, Inc
$56
Kiniksa Pharmaceuticals, Ltd.
$52
AtriCure, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$42
Cardiovascular Systems Inc.
$41
CHIESI USA, INC.
$40
Veryan Medical Incorporated
$40
Astellas Pharma US Inc
$38
Impulse Dynamics (USA) Inc.
$35
Kowa Pharmaceuticals America, Inc.
$30
Inspire Medical Systems, Inc.
$25
CVRx, Inc.
$22
Aegerion Pharmaceuticals, Inc.
$22
Acarix USA Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
SCPHARMACEUTICALS INC.
$18
ShockWave Medical, Inc
$17
Phadia US Inc.
$17
VivaQuant Inc, dba Rhythm Express
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
(4067) Tack Endovascular Systems BTK · Adempas · Arcalyst · Assure WCD · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BRILINTA · BYSTOLIC · Barostim Neo System · BioMimics · CADScor System · CAMZYOS · CHANTIX · CLEVIPREX · ClosureFast · Concerto · Confirm Rx · Corlanor · Diamondback Peripheral · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FUROSCIX · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL VASCULAR INTERVENTION · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL VASCULAR INTERVENTION · GENERAL - VASCULAR INTERVENTION · GENERAL ANGIOGRAPHY · GENERAL PAIN MANAGEMENT · GENERAL VASCULAR INTERVENTION · General - Angiography · General - Vascular Intervention · HeartMate Touch · IGT Devices Und · IGT_D Peripheral · INSPIRE · ImmunoCAP · Impella · JARDIANCE · JETSTREAM · JUXTAPID · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · Livalo · MITRACLIP · MULTAQ · MitraClip System · NEXLETOL · NHancer Rx · No Associated Product · OPTIMIZER · Ozempic · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · REVEAL LINQ · ROTALINK · Repatha · Rhythm Express · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SQRX PULSE GENERATOR · SYNERGY · VARITHENA · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · VenaSeal · Visions PV .035 · WALLSTENT · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent System · ZONTIVITY · Zephyr Pacemaker
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
24
Per 100K population
9.2
County median income
$138,000
Nearest hospital
NORTHSIDE HOSPITAL FORSYTH
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Beach is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 6% in GA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Beach experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Beach performed 1,576 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beach receive payments from pharmaceutical companies?
Yes. Dr. Beach received a total of $13,302 from 52 companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beach's costs compare to other interventional cardiologists in Cumming?
Dr. Beach's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Cumming
Browse interventional cardiologists in Cumming ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in GA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in GA
Which GA interventional cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology